SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

2.

Pickleball program boosts health and wellness for cancer survivors, study finds

3.

Medical Journal March 28, 2023

4.

New methods show how fast breast cancers grow and how surgery delays affect cancer staging

5.

New opportunities for screening and treatment have been created by the identification of the genetic drivers of esophageal cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot